Bodo Haas

6PUBLICATIONS
15CO-AUTHORS
Environmental biogeochemistryCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 02, 2026
The in vitro alkaline comet assay with liver models as a complementary tool for genotoxicity assessment of N-nitrosamines.

|Mar 24, 2025
Apoptotic and senolytic effects of hERG/Eag1 channel blockers in combination with temozolomide in human glioblastoma cells.

Bodo Haas, Inken Roth, Luisa Säcker

|Dec 14, 2020
Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent.

Bodo Haas, Janine Ciftcioglu, Sanja Jermar

|Sep 26, 2020
Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells.

Bernd Kaina, Lea Beltzig, Andrea Piee-Staffa

|Sep 26, 2018
Thioredoxin Confers Intrinsic Resistance to Cytostatic Drugs in Human Glioma Cells.

Bodo Haas, Lena Schütte, Maria Wos-Maganga

|May 15, 2018
Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs.

Bodo Haas, Veronika Klinger, Christina Keksel

Pageof 1

Frequent Collaborators

1 joint publications

M A Djuari

1 joint publications

A Londenberg

1 joint publications

A Bassan

1 joint publications

K Cross